#Stigmatisierung und #Diabetes: @RenzaS und @Jazzsethi95 haben #DiabetesStigma in einem offenen Brief thematisiert, um darauf aufmerksam zu machen. Eine deutsche Version des Briefes findet ihr hier:
https://luckyloop.koeln/languagematters/
#LanguageMatters #dedoc #ADA2023
#stigmatisierung #diabetes #diabetesstigma #languagematters #dedoc #ada2023
Yesterday at #ADA2023 when Ania Jastreboff presented efficacy for #retatrutide in #obesity the hundreds of scientists in attendance spontaneously applauded. This was effectiveness never seen before – a stunning advance.
https://conscienhealth.org/2023/06/ada2023-an-amazing-3-in-1-obesity-medicine/
#ada2023 #retatrutide #obesity
RT @EricTopol :
Not every day you see an anti-obesity drug that has an average of >24% body weight loss 🆕 @NEJM #ADA2023 https://www.nejm.org/doi/full/10.1056/NEJMoa2301972 Triple receptor agonist weight loss exceeds prior GLP-1 drugs (and dual receptor agents) and has yet to plateau
At #ADA2023 yesterday, we heard excellent presentations from Barbara Rolls, Christopher Gardner & KevinHall, doing their best to explain what constitutes #HealthyFood and healthy #EatingPatterns. This might be the song that doesn't end.
https://conscienhealth.org/2023/06/ada2023-a-frustrating-quest-for-healthy-food/
#ada2023 #healthyfood #eatingpatterns
At #ADA2023 in San Diego, the tides were rolling in with the promise of a wealth of new, effective options on the way for treating #obesity. Plus new publications in #NEJM and #Lancet.
#ADARME
https://conscienhealth.org/2023/06/ada2023-in-san-diego-watching-tides-roll-in/
#ada2023 #obesity #nejm #lancet #adarme